Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bregni

Showing results (61-70 of 102) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myelomaA M Gianni, C Tarella, M Bregni, et al.
Bone Marrow Transplantation|April 1, 1993
Role of chemotherapy and GM-CSF on hemopoietic progenitor cell mobilization in multiple myelomaC Tarella, M Boccadoro, P Omedé, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1990
Total body irradiation and high-dose melphalan with bone marrow transplantation at Istituto Nazionale Tumori, Milan, ItalyL Gandola, F Lombardi, S Siena, et al.
Bone Marrow Transplantation|August 1, 1995
Circulating progenitors following high-dose sequential (HDS) chemotherapy with G-CSF: short intervals between drug courses severely impair progenitor mobilizationC Tarella, D Caracciolo, P Gavarotti, et al.
Bone Marrow Transplantation|September 1, 1996
Benefits of blood cell transplant cryopreservation with oxypolygelatine (Gelifundol) plasma substituteM Di Nicola, S Siena, M Bregni, et al.
Stem Cells (Dayton, Ohio)|July 1, 1993
Clinical implications of the heterogeneity of hematopoietic progenitors elicited in peripheral blood by anticancer therapy with cyclophosphamide and cytokine(s)S Siena, M Bregni, L Bonsi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapyM Bregni, S Siena, M Di Nicola, et al.
British Journal of Haematology|June 1, 1991
Selective purging by human interleukin-2 activated lymphocytes of bone marrows contaminated with a lymphoma line or autologous leukaemic cellsC Gambacorti-Passerini, L Rivoltini, M Fizzotti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1994
Durability of hematopoiesis following autografting with peripheral blood hematopoietic progenitorsS Siena, M Bregni, M Di Nicola, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1993
High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease--a 6-year updateA M Gianni, S Siena, M Bregni, et al.
Pageof 11

Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myelomaA M Gianni, C Tarella, M Bregni, et al.
Bone Marrow Transplantation|April 1, 1993
Role of chemotherapy and GM-CSF on hemopoietic progenitor cell mobilization in multiple myelomaC Tarella, M Boccadoro, P Omedé, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 1, 1990
Total body irradiation and high-dose melphalan with bone marrow transplantation at Istituto Nazionale Tumori, Milan, ItalyL Gandola, F Lombardi, S Siena, et al.
Bone Marrow Transplantation|August 1, 1995
Circulating progenitors following high-dose sequential (HDS) chemotherapy with G-CSF: short intervals between drug courses severely impair progenitor mobilizationC Tarella, D Caracciolo, P Gavarotti, et al.
Bone Marrow Transplantation|September 1, 1996
Benefits of blood cell transplant cryopreservation with oxypolygelatine (Gelifundol) plasma substituteM Di Nicola, S Siena, M Bregni, et al.
Stem Cells (Dayton, Ohio)|July 1, 1993
Clinical implications of the heterogeneity of hematopoietic progenitors elicited in peripheral blood by anticancer therapy with cyclophosphamide and cytokine(s)S Siena, M Bregni, L Bonsi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapyM Bregni, S Siena, M Di Nicola, et al.
British Journal of Haematology|June 1, 1991
Selective purging by human interleukin-2 activated lymphocytes of bone marrows contaminated with a lymphoma line or autologous leukaemic cellsC Gambacorti-Passerini, L Rivoltini, M Fizzotti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1994
Durability of hematopoiesis following autografting with peripheral blood hematopoietic progenitorsS Siena, M Bregni, M Di Nicola, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1993
High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease--a 6-year updateA M Gianni, S Siena, M Bregni, et al.
Pageof 11